Certara Unveils Innovative CoAuthor Generative AI for Regulatory Writing
RADNOR, Pa., June 17, 2024 (GLOBE NEWSWIRE) -- A significant stride was made in the landscape of drug development and medical regulatory compliance with the introduction of the CoAuthor generative AI regulatory writing software by Certara, Inc. CERT, a distinguished entity in model-informed drug development. CoAuthor represents a breakthrough in the discipline of medical writing, offering sophisticated tools aimed at streamlining the preparation of compliant and high-quality regulatory documents essential for drug approval processes.
Revolutionizing Regulatory Documentation
The pharmaceutical industry is on the brink of transformation with Certara’s launch of CoAuthor, a system crafted to leverage generative artificial intelligence. This groundbreaking software automates elements of regulatory writing, enabling writers to focus more on the intricate and critical aspects of their submissions. CoAuthor’s efficiency does not only reduce the time taken to draft documents but also enhances the quality and consistency of the submissions, a critical advantage in the rigorous field of medical regulatory compliance.
Expertise Backed by Advanced Technology
Certara CERT, with its headquarters nested in Princeton, New Jersey, carries a profound reputation for supplying high-caliber software products and services that underpin biosimulation in the journey of drug discovery and development. The unveiling of CoAuthor further cements the company's role as an innovator in the pharmaceutical technology landscape.
In parallel, MSFT, the titan behind an array of acclaimed technology solutions including the likes of the Microsoft Windows operating systems, the Microsoft Office suite, and the Microsoft Surface devices, continues to shape the broader technology domain. While not directly related to Certara’s niche, the influence of Microsoft Corporation in technology innovation sets a pertinent backdrop for the potential integration of advanced software solutions in industries like pharmaceuticals and beyond.